Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
Latest Information Update: 26 Feb 2024
At a glance
- Drugs Abemaciclib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 09 Aug 2023 Planned primary completion date changed from 1 Apr 2023 to 1 Sep 2023.
- 09 Aug 2023 Status changed from suspended to active, no longer recruiting.
- 22 Feb 2023 Planned primary completion date changed from 1 Nov 2022 to 1 Apr 2023.